BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $634,035 | -19.4% | 16,800 | -2.7% | 0.24% | -15.5% |
| Q2 2023 | $787,048 | +10.8% | 17,275 | -1.4% | 0.28% | +5.3% |
| Q1 2023 | $710,408 | -17.8% | 17,515 | +3.2% | 0.26% | -19.8% |
| Q4 2022 | $864,714 | -0.6% | 16,965 | +5.0% | 0.33% | -9.6% |
| Q3 2022 | $870,000 | -16.2% | 16,155 | 0.0% | 0.36% | -10.1% |
| Q2 2022 | $1,038,000 | -15.7% | 16,155 | +1.7% | 0.40% | -3.8% |
| Q1 2022 | $1,231,000 | -9.7% | 15,880 | 0.0% | 0.42% | -6.7% |
| Q4 2021 | $1,363,000 | +7.4% | 15,880 | +0.6% | 0.45% | -2.0% |
| Q3 2021 | $1,269,000 | -0.1% | 15,785 | 0.0% | 0.46% | +0.2% |
| Q2 2021 | $1,270,000 | -9.0% | 15,785 | -4.5% | 0.46% | -12.6% |
| Q1 2021 | $1,395,000 | +7.7% | 16,535 | +2.4% | 0.52% | +2.3% |
| Q4 2020 | $1,295,000 | -0.5% | 16,145 | -0.3% | 0.51% | -10.5% |
| Q3 2020 | $1,302,000 | -6.9% | 16,195 | -0.3% | 0.57% | -11.7% |
| Q2 2020 | $1,398,000 | +5.7% | 16,245 | -0.3% | 0.65% | -10.0% |
| Q1 2020 | $1,323,000 | -2.5% | 16,295 | +0.5% | 0.72% | +26.9% |
| Q4 2019 | $1,357,000 | -4.4% | 16,220 | 0.0% | 0.57% | -10.8% |
| Q3 2019 | $1,419,000 | +6.9% | 16,220 | 0.0% | 0.64% | +4.9% |
| Q2 2019 | $1,328,000 | +0.5% | 16,220 | -0.2% | 0.61% | -3.0% |
| Q1 2019 | $1,321,000 | +22.7% | 16,245 | -0.8% | 0.63% | +10.8% |
| Q4 2018 | $1,077,000 | -14.7% | 16,370 | 0.0% | 0.56% | -2.8% |
| Q3 2018 | $1,262,000 | +3.8% | 16,370 | -0.6% | 0.58% | -1.5% |
| Q2 2018 | $1,216,000 | +13.4% | 16,470 | 0.0% | 0.59% | +8.5% |
| Q1 2018 | $1,072,000 | 0.0% | 16,470 | -0.8% | 0.54% | +3.6% |
| Q4 2017 | $1,072,000 | +1.8% | 16,595 | -1.1% | 0.52% | -2.6% |
| Q3 2017 | $1,053,000 | +3.4% | 16,775 | -0.3% | 0.54% | -1.1% |
| Q2 2017 | $1,018,000 | +16.7% | 16,829 | 0.0% | 0.54% | +15.2% |
| Q1 2017 | $872,000 | +16.4% | 16,829 | -0.4% | 0.47% | +11.6% |
| Q4 2016 | $749,000 | -9.3% | 16,904 | -2.6% | 0.42% | -12.4% |
| Q3 2016 | $826,000 | +13.2% | 17,354 | +7.5% | 0.48% | +11.0% |
| Q2 2016 | $730,000 | +9.9% | 16,140 | -0.2% | 0.44% | +4.6% |
| Q1 2016 | $664,000 | +35.8% | 16,165 | +26.1% | 0.42% | +30.3% |
| Q4 2015 | $489,000 | – | 12,815 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |